Home › Insufficienza cardiaca › Nebraska › Omaha
Studi clinici su Insufficienza cardiaca a Omaha, NE
13 studi su Insufficienza cardiaca cercano partecipanti presso sedi a Omaha e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
In reclutamentoFase 3
- Be Well Clinical Studies, Omaha
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
In reclutamentoFase 3
- University of Nebraska Medical Center, Omaha
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
In reclutamento
- University of Nebraska Medical Center, Omaha
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
In reclutamentoFase 3
- Research Site, Omaha
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
In reclutamentoFase 3
- CON-10018, Omaha, NE, Omaha
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
In reclutamentoFase 3
- Omaha, NE Investigative Site 10018, Omaha
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
In reclutamento
- University of Nebraska Medical Center, Omaha
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
In reclutamentoStudio osservazionale
- Omaha, Omaha
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
In reclutamentoStudio osservazionale
- CHI Health Reseach Center, Omaha
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
In reclutamentoFase 3
- Tenax Investigational Site, Omaha
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
In reclutamento
- University of Nebraska Medical Center, Omaha
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
In reclutamento
- University of Nebraska Medical Center, Omaha
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
In reclutamentoFase 4
- Creighton University Medical Center, Omaha
Studi su Insufficienza cardiaca in altre città
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- St. Louis, MO26 studi
- Durham, NC26 studi
- Kansas City, MO25 studi
- Atlanta, GA25 studi
Altri studi a Omaha
- Cancro alla prostata27 studi
- Cancro del polmone non a piccole cellule24 studi
- Cancro al seno22 studi
- Cancro colorettale18 studi
- Cancro (tutti i tipi)18 studi
- Mieloma multiplo16 studi
- Linfoma non Hodgkin14 studi
- Cancro ovarico14 studi
- Cancro pancreatico14 studi
- Carcinoma a cellule squamose della testa e del collo13 studi
- Cancro metastatico13 studi
- Cancro al rene (carcinoma a cellule renali)12 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.